Nula Therapeutics
St. Petersburg, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 2 known investors
Find your way into Nula Therapeutics
494 people in our graph share verified history with the Nula Therapeutics team — schools, employers, funds. One of them is your warm intro.
Giovanni Mariggiunlockedknows Christopher R. Shepard · together at Deallus Consulting (overlapped)
×2knows the team · via Massachusetts Institute of Technology
×6knows the team · via Wake Forest University
×2knows the team · via Carnegie Mellon University - Tepper School of Business
knows the team · via Genentech
Founders & leadership
CS

Christopher ShepardinChief Executive Officer, Board of Directors, Co-FounderVenture Partner at Apollo Health Ventures
JR
Jarod RutledgeNamed on SEC filing
Board
NR
Nils ReggeBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 1 round · 2026
▶$7.4MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jarod RutledgeDirector
- Christopher ShepardExecutive Officer, Director
- Nils ReggeDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Nula Therapeutics's investors?
- Nula Therapeutics's investors include Korify Capital, Apollo Health Ventures.
- How much funding has Nula Therapeutics raised?
- Nula Therapeutics has disclosed $7.4M raised across 1 round.
- Where is Nula Therapeutics headquartered?
- Nula Therapeutics is headquartered in St. Petersburg, US.

